Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis

NCT03928184 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

501

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: Lorecivivint
DRUG: Placebo

Sponsor

Biosplice Therapeutics, Inc.